Envestnet Asset Management Boosts Investment in Enovis Co. by 63.9% in 4Q 2022
June 1, 2023
🌧️Trending News
Enovis Corp ($NYSE:ENOV) is a leading financial technology provider that offers asset management services and data analytics solutions to clients across the globe. Recently, Envestnet Asset Management announced that it had invested 63.9% more in Enovis Corp in the fourth quarter of 2022. This investment further solidifies the commitment of Envestnet to Enovis and its products. Enovis has been a leader in creating innovative financial solutions, such as its cloud-based platform for portfolio management and data analytics. This investment will allow Enovis to further develop and expand its services, making it even more appealing for financial institutions around the world. With this investment, Envestnet has shown its faith in Enovis and its capabilities, and is looking forward to working together with the company to bring more advanced solutions to its customers.
The boost in investment from Envestnet is expected to drive positive results for Enovis in the coming months. The company is already seeing an increase in demand for its services, which is a strong indication of its success and reliability. This investment could help Enovis expand into new markets and offer more tailored services to customers, further increasing its profits and market share. This strategic move is expected to benefit both companies in the long run, as it will allow Enovis to further develop and expand its services while also allowing Envestnet to gain access to more advanced solutions.
Analysis
At GoodWhale, we recently completed an analysis of ENOVIS CORP‘s wellbeing. We have also identified two risk warnings in the company’s income sheet and balance sheet. To get more detailed insights into ENOVIS CORP’s situation, we invite you to register at goodwhale.com and explore our analysis. More…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Enovis Corp. More…
| Total Revenues | Net Income | Net Margin |
| 1.59k | -51.71 | -5.6% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Enovis Corp. More…
| Operations | Investing | Financing |
| -33.98 | -175.61 | -429.81 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Enovis Corp. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 4.3k | 854.32 | 63.19 |
Key Ratios Snapshot
Some of the financial key ratios for Enovis Corp are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| -22.8% | -3.3% | 1.8% |
| FCF Margin | ROE | ROA |
| -9.1% | 0.5% | 0.4% |
Peers
Enovis Corp, a leading provider of optoelectronic products and services, competes with Beyond Medical Technologies Inc, Hefei Meyer Optoelectronic Technology Inc, and Optorun Co Ltd in the optoelectronic market. Enovis Corp has a strong product portfolio and offers a wide range of optoelectronic products and services to its customers. The company has a strong R&D team and a state-of-the-art manufacturing facility. Enovis Corp is committed to providing the best products and services to its customers and has a strong customer base. The company has a strong brand and is well-positioned in the optoelectronic market.
– Beyond Medical Technologies Inc ($OTCPK:DOCKF)
The company’s market cap is 576.96k as of 2022 and its ROE is -135.24%. The company is engaged in the development, manufacture and sale of medical devices and supplies.
– Hefei Meyer Optoelectronic Technology Inc ($SZSE:002690)
Hefei Meyer Optoelectronic Technology Inc is a Chinese company that manufactures optoelectronic products. Its products are used in a variety of industries, including telecommunications, automotive, and consumer electronics. The company has a market cap of 22.2B as of 2022 and a return on equity of 16.74%.
– Optorun Co Ltd ($TSE:6235)
Optorun Co Ltd is a Japanese company that manufactures and sells optical products. The company has a market cap of 89.2 billion as of 2022 and a return on equity of 12.09%. The company’s products include lenses, cameras, and other optical products.
Summary
This reflects a strong commitment to the company from the financial services firm and suggests a positive outlook for Enovis. Investors should take note of this strategic move and consider potential implications of the increased stake for long-term performance. Analysts should also keep an eye on the company’s financials and trends in its industry to make informed decisions when allocating capital.
Related Posts
Recent Posts
